ZEN Graphene Solutions, formerly called Zenyatta Ventures, is a mineral exploration and development company based in Ontario, Canada. Zen is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zen has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to the Zen, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
The latest ZEN Graphene news:
ZEN Graphene Solutions partners with Evercloak and NGen for Graphene in Cleantech manufacturing project
ZEN Graphene Solutions has announced that Evercloak and ZEN have been awarded CAD$125,000 (around USD$92,000) each as part of a Next Generation Manufacturing Canada (NGen) Project.
The project entitled “Advancing Large-Scale Graphene and Thin-Film Membrane Manufacturing” will support the scale up of graphene oxide (GO) production by ZEN to supply GO to Evercloak for their scale up and optimizing activities. NGen supports collaborative technology projects that enable the development of world-leading advanced manufacturing capabilities in Canada.
After recently closing the first tranche of its private placement, Zen Graphene Solutions has now announced the closing of the second tranche. The Company raised total gross proceeds of CAD$2,049,999.80 (around USD$1.5 million) under the Offeringץ
According to Zen, the funds will be used for ongoing work on the Albany Graphite Project including graphene research and scale up, COVID-19 initiatives and other graphene applications development and for general corporate purposes.
Zen Graphene Solutions has announced the closing of the first tranche of its previously announced private placement of units.
The Company raised gross proceeds of CAD$1,077,294.80 (around USD $788,115) under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including graphene research and scale up, COVID-19 initiatives and other graphene applications development and for general corporate purposes. A second tranche is expected to close shortly in line with previous interest received.
ZEN Graphene Solutions has announced it will be launching a new research collaboration with Prof. Mohammad Arjmand and his team at the University of British Columbia (UBC)‐Okanagan Campus, with a $200,000 Department of National Defence (DND) Innovation for Defense Excellence and Security (IDEaS) award.
ZEN will be providing in-kind contributions of Albany Pure materials and consultation with its technical team.The goal of this collaborative research project is to develop electrically conductive, molded and 3D printed graphene/polymer nanocomposites as more versatile replacements for metallic electromagnetic shields that are currently in use.
Zen Graphene Solutions and Graphene Composites collaborate on graphene ink on fabrics for Coronavirus protection
ZEN Graphene Solutions has announced an international collaboration with UK-based Graphene Composites to fight COVID-19 by developing a potential virucidal graphene-based composite ink that can be applied to fabrics including N95 face masks and other personal protective equipment (PPE) for significantly increased protection. Once the development, testing, and confirmation of the graphene ink's virucidal ability have been completed, the ink will then be incorporated into fabrics used for PPE.
Francis Dubé, CEO of ZEN commented, "We are pleased to be collaborating with GC and be on the forefront of a new innovative technology that could contribute to combating the deadly COVID-19 virus. The development of this potential COVID-19 virucidal graphene ink is coming at a crucial time to provide effective PPE supplies for the safety of frontline workers and hospital staff." Dr. Dubé continued, "The current N95 masks trap the virus but don't kill it. Our testing will demonstrate if the graphene ink is an effective virucide which would kill the virus as this could make a big difference to people's safety. We have been very impressed by the Graphene Composites team and look forward to continued collaborations."